Magnifying the problem When lockdowns first hit back in March 2020 I was pretty sure the capital markets and the psychedelic sector would suffer. It was a burgeoning…
July 13, 2021
Thirty years ago, advertisers would buy time on NBC and hope that viewers didn’t nod off or go the washroom while the ad was playing. The eye-balls paid for…
Valeo Pharma’s (VPH.C) low molecular weight heparin (LMWH) drug, Redesca and Redesca HP, is now eligible for public reimbursement in seven provinces and territories across Canada, as well as…
Fission Uranium (FCU.T) announced the assay results from their winter 2021 resource expansion drill program at their PLS Project. The assays confirmed high-grade mineralization on multiple lines between line…
Hepion Pharmaceuticals (HEPA.Q) today announced positive topline results from its Phase 2a ‘AMBITION’ NASH clinical trial. Additionally, all primary endpoints of the trial were met. “In order to embark…
Kwesst Micro Systems (KWE.V) will be launching their Low Energy Cartridge (LEC) product line at the 2022 SHOT Show in Las Vegas in January, according to a press release….
The drama in the markets for the past few months have been Shakespearean: To Taper or Not to Taper, that is the question. When does the Fed start raising…
PsyBio Therapeutics (PSYB.V) announced it has filed a new provisional patent application with the US Patent and Trademark Office. The new patent is entitled Psilocybin and Norbaeocystin Compositions and…
High Tide (HITI.V) announces today that it has entered into a share purchase agreement with the shareholders of 102105699 Saskatchewan Ltd. pursuant to which High Tide will acquire all…
Cybin (CYBN.NE) announced it has filed their 13th provisional patent application and is building out its digital therapeutics strategy. Cybin did not go into detail about the patent application,…